Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fluocinolone recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Fluocinolone (36 total). Check the affected lots below.

Most common reason: Wrong potency / content (21 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluocinolone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fluocinolone recalls on record

none so far in 2026; 36 on record, newest first
Class II · Moderate risk

Fluocinolone Acetonide Oil

Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

Terminated Failed specification Glenmark Pharmaceuticals Inc., USA NDC 68462-185-56 D-0259-2024
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020
Class II · Moderate risk

Formula 82F

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1423-2020
Class II · Moderate risk

Fluocinolone Acetonide Topical Solution

Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.

Terminated Impurity / degradation Lupin Somerset NDC 43386-069-60 D-0390-2019
Class II · Moderate risk

Fluocinolone Acetonide Topical Solution

Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0591-2990-60 D-0909-2018